With the observations of immune complexes or antigens in the circulation of patients with rheumatoid arthritis (1, 2), systemic lupus erythematosus (3, 4), and other diseases, much attention has been drawn to their possible significance in the pathogenesis of the lesions in these disorders. Abundant data derived from experimental models have shown that the presence of complexes in the circulation coincides temporally with the development of the lesions, e.g., acute glomerulonephritis and vasculitis (5, 6) and chronic glomerulonephritis (7). In these studies the complexes were demonstrable in the lesions, and it was reasonably presumed that they reached their destination in the tissues after passage through the circulation.Previous studies in this series have analyzed the mechanisms by which circulating immune complexes are capable of localizing in vessel walls. It was found that complexes localized in blood vessd walls only during an increase in vascular permeability and that the complexes were trapped along the vascular basement membranes during the passage of plasma fluids through the permeable membrane (8). The increase of vascular permeability was brought about in particular by vasoactive amines and histamine that were released from their tissue reservoirs, the mast cells, by the action of the complexes themselves (9). The accompanying article presents data suggesting that this mechanism of localization is instrumental in serum sickness.The present paper deals with the physicochemical properties of complexes and with the concentration of complexes in the plasma required for detectable localization to occur. The validity of these findings is tested in experimental serum sickness of rabbits, a disease known to be caused by deposition of circulating immune complexes. A preliminary report has been presented (10).